Table 2.
Demographic and clinical characteristics of ATB patients with negative and positive T-SPOT results.
| Variables | ATB with negative T-SPOT result (n = 10) | ATB with positive T-SPOT result (n = 39) | P* |
|---|---|---|---|
| Age, years | 52 (26-56) | 48 (29-61) | 0.673 |
| Sex, male, % | 5 (50%) | 22 (56.41%) | 0.716 |
| TB history | 3 (30%) | 8 (20.51%) | 0.521 |
| Presence of BCG scar | 4 (40%) | 17 (43.59%) | 0.838 |
| Underlying condition or illness | |||
| Diabetes mellitus | 2 (20%) | 5 (12.82%) | 0.563 |
| Solid tumor | 1 (10%) | 4 (10.26%) | 0.981 |
| Hematological malignancy | 0 (0%) | 1 (2.56%) | 1 |
| End-stage renal disease | 1 (10%) | 3 (7.69%) | 1 |
| Liver cirrhosis | 0 (0%) | 2 (5.13%) | 1 |
| Organ transplantation | 1 (10%) | 1 (2.56%) | 0.37 |
| Immunosuppressive condition† | 2 (20%) | 5 (12.82%) | 0.563 |
| Positive mycobacterial culture | 8 (80%) | 32 (82.05%) | 0.881 |
| Positive GeneXpert MTB/RIF | 7 (70%) | 29 (74.36%) | 0.781 |
ATB, active tuberculosis; BCG, bacille Calmette-Guérin; TB, tuberculosis
*Comparisons were performed between these two groups using Mann-Whitney U test, chi-square test, or Fisher’s exact test. †Patients who underwent organ transplantation, chemotherapy, or took immunosuppressants within 3 months. Data were presented as medians (25th-75th percentiles), or numbers (percentages).